Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease

Early Phase 1

Withdrawn

Conditions: Amyloid
Amyloidosis
AL Amyloidosis

Interventions: Drug: Selinexor
Drug: Dexamethasone

First Posted Date: 2021-07-30

Last Posted Date: 2022-11-17

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04984330

Locations: 🇺🇸
Weill Cornell Medicine - Multiple Myeloma Center, New York, New York, United States

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2021-07-30

Last Posted Date: 2025-05-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 33

Registration Number: NCT04984343

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇬🇧
Genesis Care, Oxford, United Kingdom

Accelerated TMS for Depression and OCD

Not Applicable

Recruiting

Conditions: Depression
OCD

Interventions: Device: MagVenture MagPro System with Brainsight neuronavigation device

First Posted Date: 2021-07-29

Last Posted Date: 2025-03-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 500

Registration Number: NCT04982757

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis

Not Applicable

Terminated

Conditions: Crohn's Disease of Large Intestine
Malignant Neoplasm of Colon

Interventions: Device: Obtaining bowel gas samples

First Posted Date: 2021-07-16

Last Posted Date: 2025-06-06

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 3

Registration Number: NCT04964297

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Small-cell Lung Cancer

Interventions: Drug: Carboplatin
Drug: Cisplatin
Drug: Etoposide
Drug: Durvalumab
Radiation: Stereotactic Body Radiotherapy

First Posted Date: 2021-07-06

Last Posted Date: 2024-11-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 6

Registration Number: NCT04951115

Locations: 🇺🇸
New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York-Presbyterian Queens, Flushing, New York, United States

Implementing a Family Caregiver Checklist in Primary Care: A Pilot Study

Not Applicable

Completed

Conditions: Caregiver Burnout

Interventions: Behavioral: Usual Care
Behavioral: Collaborative Healthcare Encounters with Caregivers (CHEC)

First Posted Date: 2021-07-01

Last Posted Date: 2025-01-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 111

Registration Number: NCT04946942

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: 225Ac-J591
Drug: Pembrolizumab
Drug: Androgen receptor pathway inhibitor
Diagnostic Test: 68Ga-PSMA-11

First Posted Date: 2021-06-30

Last Posted Date: 2024-10-16

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 76

Registration Number: NCT04946370

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
New York Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
New York Presbyterian/Weill Cornell Medical Center, New York, New York, United States

and more 1 locations

Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury

Completed

Conditions: Acquired Brain Injury

First Posted Date: 2021-06-29

Last Posted Date: 2021-06-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 73

Registration Number: NCT04943835

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Phase 4

Completed

Conditions: Nail Diseases

Interventions: Device: Platelet-poor plasma
Device: Platelet-rich plasma

First Posted Date: 2021-06-28

Last Posted Date: 2024-04-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 11

Registration Number: NCT04941807

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Delirium in Children Undergoing Stem Cell Transplantation

Active, not recruiting

Conditions: Delirium
Stem Cell Transplant Complications

Interventions: Other: Daily screening for delirium

First Posted Date: 2021-06-24

Last Posted Date: 2024-07-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1041

Registration Number: NCT04937400

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
St Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy